| pubmed-article:11280547 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11280547 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:11280547 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:11280547 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:11280547 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:11280547 | lifeskim:mentions | umls-concept:C0750491 | lld:lifeskim |
| pubmed-article:11280547 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11280547 | pubmed:dateCreated | 2001-3-30 | lld:pubmed |
| pubmed-article:11280547 | pubmed:abstractText | Confronted with nonspecific symptoms, accurate screening tests would be useful to clinicians to distinguish between functional childhood disorders and inflammatory bowel disease (IBD), thus avoiding invasive diagnostic testing. Traditional ulcerative colitis-specific perinuclear antineutrophil cytoplasmic antibody (pANCA) and Crohn's disease-specific anti-Saccharomyces cerevisiae antibody (ASCA) serodiagnostic assays have recently been modified, with ELISA cut-off values recalculated to maximize sensitivity. The aim of this study was to determine whether the combination of these serodiagnostic tests could maximize diagnostic accuracy and minimize invasive investigations in pediatric patients presenting with nonspecific symptoms suggestive of IBD. | lld:pubmed |
| pubmed-article:11280547 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11280547 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11280547 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11280547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11280547 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11280547 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11280547 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:11280547 | pubmed:issn | 0002-9270 | lld:pubmed |
| pubmed-article:11280547 | pubmed:author | pubmed-author:TarganS RSR | lld:pubmed |
| pubmed-article:11280547 | pubmed:author | pubmed-author:SeidmanE GEG | lld:pubmed |
| pubmed-article:11280547 | pubmed:author | pubmed-author:UrmanMM | lld:pubmed |
| pubmed-article:11280547 | pubmed:author | pubmed-author:OfmanJ JJJ | lld:pubmed |
| pubmed-article:11280547 | pubmed:author | pubmed-author:DubinskyM CMC | lld:pubmed |
| pubmed-article:11280547 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11280547 | pubmed:volume | 96 | lld:pubmed |
| pubmed-article:11280547 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11280547 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11280547 | pubmed:pagination | 758-65 | lld:pubmed |
| pubmed-article:11280547 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:meshHeading | pubmed-meshheading:11280547... | lld:pubmed |
| pubmed-article:11280547 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11280547 | pubmed:articleTitle | Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. | lld:pubmed |
| pubmed-article:11280547 | pubmed:affiliation | Department of Pediatrics, University of Montreal, Quebec, Canada. | lld:pubmed |
| pubmed-article:11280547 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11280547 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11280547 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11280547 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11280547 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11280547 | lld:pubmed |
